NGEN

NERVGEN PHARMA CORP.

NASDAQ · Biotechnology mkt cap 245,151,600
Company page ›Healthcare ›Biotechnology
High confidence Medium Low Unknown
Line thickness = strength · colour = confidence

Drawing the 24 strongest — 82 further edges are not on this diagram

Relationships 24 of 106

Capped at 24 strongest — 82 not shown

Co-mentioned in news 1

Both companies were named in the same news article. Co-mention is adjacency, not a business relationship.

BAINF BASE INC Graph ›
0.00 conf n/a
Peer similarity 23

Computed by us from market capitalisation, earnings cadence, dividend frequency and exchange. Not a reported relationship.

CHRS Coherus Oncology, Inc. Graph ›
1.00 conf 1.00
ALXO ALX ONCOLOGY HOLDINGS INC Graph ›
1.00 conf 1.00
ABOS Acumen Pharmaceuticals, Inc. Graph ›
1.00 conf 1.00
ANTX AN2 Therapeutics, Inc. Graph ›
1.00 conf 1.00
FATE FATE THERAPEUTICS INC Graph ›
1.00 conf 1.00
KRRO Korro Bio, Inc. Graph ›
0.99 conf 1.00
IMRX Immuneering Corp Graph ›
0.99 conf 1.00
CLLS Cellectis S.A. Graph ›
0.98 conf 1.00
LYEL Lyell Immunopharma, Inc. Graph ›
0.98 conf 1.00
UPB Upstream Bio, Inc. Graph ›
0.98 conf 1.00
RZLT Rezolute, Inc. Graph ›
0.96 conf 1.00
INO INOVIO PHARMACEUTICALS, INC. Graph ›
0.96 conf 1.00
TLSA Tiziana Life Sciences Ltd Graph ›
0.96 conf 1.00
PRTA PROTHENA CORP PUBLIC LTD CO Graph ›
0.96 conf 1.00
PMN ProMIS Neurosciences Inc. Graph ›
0.96 conf 1.00
OVID Ovid Therapeutics Inc. Graph ›
0.95 conf 1.00
DWTX Dogwood Therapeutics, Inc. Graph ›
0.93 conf 1.00
ALLO Allogene Therapeutics, Inc. Graph ›
0.93 conf 1.00
CING Cingulate Inc. Graph ›
0.92 conf 1.00
GERN GERON CORP Graph ›
0.90 conf 1.00
GLUE Monte Rosa Therapeutics, Inc. Graph ›
0.89 conf 1.00
REPL Replimune Group, Inc. Graph ›
0.87 conf 1.00
TSHA Taysha Gene Therapies, Inc. Graph ›
0.85 conf 1.00

Edge strength is relative to the strongest edge in this view and is not comparable across views. Confidence is the mean confidence of the active evidence behind an edge, on an absolute scale. Peer-similarity edges are computed by us and are not a reported relationship; co-mention edges record that two companies appeared in the same article, which is adjacency rather than a business connection.